Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
HSPA12A maintains aerobic glycolytic homeostasis and Histone3 lactylation in cardiomyocytes to attenuate myocardial ischemia/reperfusion injury
Wansu Yu, … , Zhengnian Ding, Li Liu
Wansu Yu, … , Zhengnian Ding, Li Liu
Published February 29, 2024
Citation Information: JCI Insight. 2024;9(7):e169125. https://doi.org/10.1172/jci.insight.169125.
View: Text | PDF
Research Article Cardiology Cell biology

HSPA12A maintains aerobic glycolytic homeostasis and Histone3 lactylation in cardiomyocytes to attenuate myocardial ischemia/reperfusion injury

  • Text
  • PDF
Abstract

Myocardial ischemia/reperfusion (MI/R) injury is a major cause of adverse outcomes of revascularization following myocardial infarction. Anaerobic glycolysis during myocardial ischemia is well studied, but the role of aerobic glycolysis during the early phase of reperfusion is incompletely understood. Lactylation of Histone H3 (H3) is an epigenetic indicator of the glycolytic switch. Heat shock protein A12A (HSPA12A) is an atypic member of the HSP70 family. In the present study, we report that, during reperfusion following myocardial ischemia, HSPA12A was downregulated and aerobic glycolytic flux was decreased in cardiomyocytes. Notably, HSPA12A KO in mice exacerbated MI/R-induced aerobic glycolysis decrease, cardiomyocyte death, and cardiac dysfunction. Gain- and loss-of-function studies demonstrated that HSPA12A was required to support cardiomyocyte survival upon hypoxia/reoxygenation (H/R) challenge and that its protective effects were mediated by maintaining aerobic glycolytic homeostasis for H3 lactylation. Further analyses revealed that HSPA12A increased Smurf1-mediated Hif1α protein stability, thus increasing glycolytic gene expression to maintain appropriate aerobic glycolytic activity to sustain H3 lactylation during reperfusion and, ultimately, improving cardiomyocyte survival to attenuate MI/R injury.

Authors

Wansu Yu, Qiuyue Kong, Surong Jiang, Yunfan Li, Zhaohe Wang, Qian Mao, Xiaojin Zhang, Qianhui Liu, Pengjun Zhang, Yuehua Li, Chuanfu Li, Zhengnian Ding, Li Liu

×

Figure 2

Downregulation of HSPA12A contributed to MI/R injury.

Options: View larger image (or click on image) Download as PowerPoint
Downregulation of HSPA12A contributed to MI/R injury.
(A) Mouse experime...
(A) Mouse experimental protocol. (B) The absence of HSPA12A expression in hearts of Hspa12a–/– mice was demonstrated by immunoblotting. n = 10 mice/group. (C) Cardiac function was evaluated 3 hours after MI/R by echocardiography. n = 6/group. (D) Infarct size was examined 24 hours after MI/R. The infarct regions were shown as pale white with TTC staining. The ischemia risk area was illustrated by Evan’s blue nonstained areas. n = 6 mice/group. (E) Apoptosis in cardiomyocytes was examined 3 hours after MI/R by TUNEL assay on the paraffin-embedded sections that prepared from cardiac tissues at papillary muscles. α-Actinin was used to stain cardiomyocytes, and DAPI was used to counterstain the nuclei. Scale bars: 50 μm. n = 5/group. Data are shown as mean ± SD. ***P < 0.001, **P < 0.01, and *P<0.05 by 2-way ANOVA followed by post hoc test (C and E) or Student’s 2-tailed unpaired t test (D).

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts